Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Relationship between plasma selenium concentrations and lower genital tract levels of HIV-1 RNA and interleukin type 1β

Abstract

Objective:

To examine the relationship between selenium nutritional status and intermediates of human immunodeficiency virus (HIV)-1 transmission.

Design:

Prospective cohort study.

Setting:

A study clinic at Muhimbili National Hospital, Dar es Salaam, Tanzania.

Subjects:

A total of 340 HIV-1-infected pregnant women with gestational ages 12–27 weeks.

Methods:

Women's plasma selenium concentrations were determined at enrollment and modeled as tertiles (tertile 1: <114 μg/l (reference); tertile 2: 114–131 μg/l; tertile 3: >131 μg/l). Cervicovaginal lavage specimens were obtained at 36 weeks of gestation to determine HIV-1 RNA and interleukin-1β (IL-1β) levels. In subgroup analyses, 123 women with genital tract infections at enrollment were excluded.

Results:

Plasma selenium concentrations 114 μg/l were related to increased risk of lower-genital shedding of HIV-1 RNA. Excluding women with genital tract infections strengthened the associations (relative risk (RR) tertile 2: 1.46, 95% confidence interval (CI)=1.10, 1.92; RR tertile 3: 1.39, 95% CI=1.05, 1.84). There was evidence for an association between plasma selenium concentrations 114 μg/l and increased HIV-1 RNA levels among the entire cohort and after excluding women with genital tract infections. There was no association between plasma selenium and IL-1β concentrations.

Conclusions:

High selenium status may lead to increased risk of genital HIV-1 shedding, but data from other studies indicate that the evidence is mixed. Results from ongoing selenium trials are awaited to clarify the impact of selenium on HIV-1-related transmission endpoints.

Sponsorship:

National Institute of Child Health and Human Development (NICHD R01 32257) and the Fogarty International Center (NIH D43 TW00004).

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  • Baeten JM, Mostad SB, Hughes MP, Overbaugh J, Bankson DD, Mandaliya K et al. (2001). Selenium deficiency is associated with shedding of HIV-1-infected cells in the female genital tract. J Acquir Immune Defic Syndr 26, 360–364.

    Article  CAS  Google Scholar 

  • Burton GW, Ingold KU (1984). beta-Carotene: an unusual type of lipid antioxidant. Science 224, 569–573.

    Article  CAS  Google Scholar 

  • Deagan JT, Butler JA, Zachara A, Whanger PD (1993). Determination of the distribution of selenium between glutathione peroxidase, selenoprotein P, and albumin in plasma. Anal Biochem 208, 176–181.

    Article  Google Scholar 

  • Diamond AM, Hu YJ, Mansur DB (2001). Glutathione peroxidase and viral replication: implications for viral evolution and chemoprevention. Biofactors 14, 205–210.

    Article  CAS  Google Scholar 

  • Drain PK, Baeten JM, Overbaugh J, Wener MH, Bankson DD, Lavreys L et al. (2006). Low serum albumin and the acute phase response predict low serum selenium in HIV-1 infected women. BMC Infect Dis 6, 85.

    Article  Google Scholar 

  • Fawzi W, Msamanga G, Antelman G, Xu C, Hertzmark E, Spiegelman D et al. (2004a). Effect of prenatal vitamin supplementation on lower-genital levels of HIV type 1 and interleukin type 1 beta at 36 weeks of gestation. Clin Infect Dis 38, 716–722.

    Article  CAS  Google Scholar 

  • Fawzi WW, Msamanga G, Hunter D, Urassa E, Renjifo B, Mwakagile D et al. (2000). A randomized trial of vitamin supplements in relation to vertical transmission of HIV-1 in Tanzania. J Acquir Immune Def Syndr 23, 246–254.

    Article  CAS  Google Scholar 

  • Fawzi WW, Msamanga GI, Spiegelman D, Urassa EJ, McGrath N, Mwakagile D et al. (1998). Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet 351, 1477–1482.

    Article  CAS  Google Scholar 

  • Fawzi WW, Msamanga GI, Spiegelman D, Wei R, Kapiga S, Villamor E et al. (2004b). A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med 351, 23–32.

    Article  CAS  Google Scholar 

  • Feldman JG, Burns DN, Gange SJ, Bacchetti P, Cohen M, Anastos K et al. (2000). Serum albumin as a predictor of survival in HIV-infected women in the Women's Interagency HIV study. AIDS 14, 863–870.

    Article  CAS  Google Scholar 

  • Feldman JG, Gange SJ, Bacchetti P, Cohen M, Young M, Squires KE et al. (2003). Serum albumin is a powerful predictor of survival among HIV-1-infected women. J Acquir Immune Defic Syndr 33, 66–73.

    Article  CAS  Google Scholar 

  • Fichorova RN, Tucker LD, Anderson DJ (2001). The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission. J Infect Dis 184, 418–428.

    Article  CAS  Google Scholar 

  • Kitano K, Baldwin GC, Raines MA, Golde DW (1990). Differentiating agents facilitate infection of myeloid leukemia cell lines by monocytotropic HIV-1 strains. Blood 76, 1980–1988.

    CAS  PubMed  Google Scholar 

  • Kupka R, Garland M, Msamanga G, Spiegelman D, Hunter D, Fawzi W (2005). Selenium status, pregnancy outcomes, and mother-to-child transmission of HIV-1. J Acquir Immune Defic Syndr 39, 203–210.

    CAS  PubMed  Google Scholar 

  • MacDonald KS, Malonza I, Chen DK, Nagelkerke NJ, Nasio JM, Ndinya-Achola J et al. (2001). Vitamin A and risk of HIV-1 seroconversion among Kenyan men with genital ulcers. AIDS 15, 635–639.

    Article  CAS  Google Scholar 

  • Mason M, Morris J, Spate V, Baskett C, Nichols T, Horsman T et al. (1998). Comparison of whole blood, plasma, and nails as monitors for the dietary intake of selenium. J Radioanal Nucl Chem 236, 29–34.

    Article  CAS  Google Scholar 

  • McClelland RS, Baeten JM, Overbaugh J, Richardson BA, Mandaliya K, Emery S et al. (2004). Micronutrient supplementation increases genital tract shedding of HIV-1 in women: results of a randomized trial. J Acquir Immune Defic Syndr 37, 1657–1663.

    Article  CAS  Google Scholar 

  • Miettinen O (1985). Theoretical Epidemiology. John Wiley & Sons: New York.

    Google Scholar 

  • Montano M, Russell M, Gilbert P, Thior I, Lockman S, Shapiro R et al. (2003). Comparative prediction of perinatal human immunodeficiency virus type 1 transmission, using multiple virus load markers. J Infect Dis 188, 406–413.

    Article  Google Scholar 

  • Mostad SB, Overbaugh J, DeVange DM, Welch MJ, Chohan B, Mandaliya K et al. (1997). Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet 350, 922–927.

    Article  CAS  Google Scholar 

  • Neve J (2000). New approaches to assess selenium status and requirement. Nutr Rev 58, 363–369.

    Article  CAS  Google Scholar 

  • Pace GW, Leaf CD (1995). The role of oxidative stress in HIV disease. Free Radic Biol Med 19, 523–528.

    Article  CAS  Google Scholar 

  • Rayman MP (2002). The argument for increasing selenium intake. Proc Nutr Soc 61, 203–215.

    Article  CAS  Google Scholar 

  • Tuomala RE, O'Driscoll PT, Bremer JW, Jennings C, Xu C, Read JS et al. (2003). Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women. J Infect Dis 187, 375–384.

    Article  Google Scholar 

  • Turpin JA, Vargo M, Meltzer MS (1992). Enhanced HIV-1 replication in retinoid-treated monocytes. Retinoid effects mediated through mechanisms related to cell differentiation and to a direct transcriptional action on viral gene expression. J Immunol 148, 2539–2546.

    CAS  Google Scholar 

  • UNAIDS (2005). AIDS Epidemic Update. UNAIDS: Geneva, Switzerland.

  • Wang CC, McClelland RS, Overbaugh J, Reilly M, Panteleeff DD, Mandaliya K et al. (2004). The effect of hormonal contraception on genital tract shedding of HIV-1. AIDS 18, 205–209.

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Institute of Child Health and Human Development (NICHD R01 32257) and the Fogarty International Center (NIH D43 TW00004).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R Kupka.

Additional information

Guarantor: R Kupka.

Contributors: GIM, DH and WWF contributed to the study design. CX and DA performed the laboratory analyses for CVL samples. RK carried out the data analyses, interpreted the results and wrote the initial draft of the manuscript. All authors participated in data interpretation and contributed to the final version of the manuscript. WWF and GIM are principal investigators of the study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kupka, R., Msamanga, G., Xu, C. et al. Relationship between plasma selenium concentrations and lower genital tract levels of HIV-1 RNA and interleukin type 1β. Eur J Clin Nutr 61, 542–547 (2007). https://doi.org/10.1038/sj.ejcn.1602567

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ejcn.1602567

Keywords

This article is cited by

Search

Quick links